AI Verdict
MRK has stronger fundamentals based on our AI analysis.
COR vs MRK Fundamental Comparison
| Metric | COR | MRK |
|---|---|---|
| Revenue | $85.9B | $65.0B |
| Net Income | $559.6M | $18.3B |
| Net Margin | 0.7% | 28.1% |
| ROE | 29.3% | 34.7% |
| ROA | 0.7% | 13.3% |
| Current Ratio | 0.92x | 1.54x |
| Debt/Equity | 4.15x | 0.89x |
| EPS | $2.87 | $7.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
COR vs MRK: Frequently Asked Questions
Is COR or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MRK has stronger fundamentals. COR is rated SELL (74% confidence) while MRK is rated BUY (80% confidence). This is not investment advice.
How does COR compare to MRK fundamentally?
Cencora, Inc. has ROE of 29.3% vs Merck & Co., Inc.'s 34.7%. Net margins are 0.7% vs 28.1% respectively.
Which stock pays higher dividends, COR or MRK?
COR has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in COR or MRK for long term?
For long-term investing, consider that COR has SELL rating with 74% confidence, while MRK has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about COR vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For COR vs MRK, the AI consensus favors MRK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.